The chart below shows how UNH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, UNH sees a -1.67% change in stock price 10 days leading up to the earnings, and a +1.71% change 10 days following the report. On the earnings day itself, the stock moves by +0.07%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Strong Financial Performance: 2024 revenues exceeded $400 billion, with adjusted earnings per share reaching $27.66, demonstrating strong financial performance within the previously set outlook ranges.
Optum Health Revenue Growth: Optum Health revenues grew to approximately $105 billion in 2024, with expectations to approach $117 billion in 2025, indicating robust growth in the care delivery segment.
Revenue and Client Growth: Optum Rx achieved revenues of over $130 billion in 2024, projected to reach about $146 billion in 2025, alongside a customer retention rate exceeding 98% and the addition of a record 750 new clients.
Revenue Projections for 2025: UnitedHealthcare's full-year revenues in 2024 approached $300 billion, with expectations to reach nearly $340 billion in 2025, driven by an increase of up to 800,000 people in Medicare Advantage offerings.
Shareholder Returns and Growth Investment: The company returned over $16 billion to shareholders through dividends and share repurchases in 2024, while also deploying nearly $17 billion in growth capital to strengthen future capabilities.
Negative
Medical Care Ratio Impact: The medical care ratio for 2024 was 150 basis points above the original outlook, resulting in a nearly $5 billion gap due to unexpected consumer mix and nearly $1 billion in business disruption from a cyberattack.
Consumer Count Decline: A drop of approximately 4 million in consumer count was noted, alongside a significant decrease in margins, attributed to strategic initiatives that deemphasized certain service areas like urgent care.
Financial Performance Challenges: The company faced nearly $6 billion in unanticipated impacts in 2024, primarily from Medicare rate cuts and the cyberattack, which hindered financial performance.
Medicare Advantage Growth Challenges: The Medicare Advantage growth was negatively impacted by unusual benefit designs in the market, leading to a lower-than-expected retention rate and overall growth in that segment.
Rising Operating Costs: Operating costs for 2024 were affected by a mix of higher-than-expected hospital coding intensity and accelerated prescribing of high-cost medications, contributing to a challenging financial environment.